Treatment-Emergent Serious Adverse Event (TESAE)

A term used in U.S. Food and Drug Administration drug trials, including for psychedelic drugs, in reference to any event not present prior to the initiation of treatments, or any event already present that worsens in either intensity or frequency following exposure to the treatments.

Was this helpful? Share it!